QQQ   440.03 (+1.09%)
AAPL   180.77 (-0.36%)
MSFT   411.42 (+0.91%)
META   489.74 (+1.18%)
GOOGL   137.92 (+1.13%)
AMZN   175.71 (+1.47%)
TSLA   202.17 (+0.06%)
NVDA   799.33 (+2.92%)
NIO   5.71 (+5.16%)
AMD   192.15 (+8.84%)
BABA   74.00 (-0.79%)
T   16.95 (-0.06%)
F   12.44 (+1.14%)
MU   90.28 (+0.64%)
CGC   3.30 (-1.79%)
GE   157.04 (+0.92%)
DIS   111.83 (+0.93%)
AMC   4.33 (-13.23%)
PFE   26.63 (-1.52%)
PYPL   60.20 (-0.08%)
XOM   104.76 (+0.42%)
QQQ   440.03 (+1.09%)
AAPL   180.77 (-0.36%)
MSFT   411.42 (+0.91%)
META   489.74 (+1.18%)
GOOGL   137.92 (+1.13%)
AMZN   175.71 (+1.47%)
TSLA   202.17 (+0.06%)
NVDA   799.33 (+2.92%)
NIO   5.71 (+5.16%)
AMD   192.15 (+8.84%)
BABA   74.00 (-0.79%)
T   16.95 (-0.06%)
F   12.44 (+1.14%)
MU   90.28 (+0.64%)
CGC   3.30 (-1.79%)
GE   157.04 (+0.92%)
DIS   111.83 (+0.93%)
AMC   4.33 (-13.23%)
PFE   26.63 (-1.52%)
PYPL   60.20 (-0.08%)
XOM   104.76 (+0.42%)
QQQ   440.03 (+1.09%)
AAPL   180.77 (-0.36%)
MSFT   411.42 (+0.91%)
META   489.74 (+1.18%)
GOOGL   137.92 (+1.13%)
AMZN   175.71 (+1.47%)
TSLA   202.17 (+0.06%)
NVDA   799.33 (+2.92%)
NIO   5.71 (+5.16%)
AMD   192.15 (+8.84%)
BABA   74.00 (-0.79%)
T   16.95 (-0.06%)
F   12.44 (+1.14%)
MU   90.28 (+0.64%)
CGC   3.30 (-1.79%)
GE   157.04 (+0.92%)
DIS   111.83 (+0.93%)
AMC   4.33 (-13.23%)
PFE   26.63 (-1.52%)
PYPL   60.20 (-0.08%)
XOM   104.76 (+0.42%)
QQQ   440.03 (+1.09%)
AAPL   180.77 (-0.36%)
MSFT   411.42 (+0.91%)
META   489.74 (+1.18%)
GOOGL   137.92 (+1.13%)
AMZN   175.71 (+1.47%)
TSLA   202.17 (+0.06%)
NVDA   799.33 (+2.92%)
NIO   5.71 (+5.16%)
AMD   192.15 (+8.84%)
BABA   74.00 (-0.79%)
T   16.95 (-0.06%)
F   12.44 (+1.14%)
MU   90.28 (+0.64%)
CGC   3.30 (-1.79%)
GE   157.04 (+0.92%)
DIS   111.83 (+0.93%)
AMC   4.33 (-13.23%)
PFE   26.63 (-1.52%)
PYPL   60.20 (-0.08%)
XOM   104.76 (+0.42%)

Eloxx Pharmaceuticals (ELOX) Short Interest Ratio & Short Volume

$0.86
+0.06 (+7.36%)
(As of 03:40 PM ET)

Eloxx Pharmaceuticals Short Interest Data

Current Short Volume
35,700 shares
Previous Short Volume
21,500 shares
Change Vs. Previous Month
+66.05%
Dollar Volume Sold Short
$136,374.00
Short Interest Ratio / Days to Cover
0.6
Last Record Date
October 15, 2023
Outstanding Shares
3,140,000 shares
Float Size
2,400,000 shares
Short Percent of Float
1.49%
Today's Trading Volume
5,429 shares
Average Trading Volume
9,830 shares
Today's Volume Vs. Average
55%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Eloxx Pharmaceuticals ?

Sign up to receive the latest short interest report for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ELOX Short Interest Over Time

ELOX Days to Cover Over Time

ELOX Percentage of Float Shorted Over Time


Eloxx Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202335,700 shares $136,374.00 +66.1%1.5%0.6 $3.82
9/30/202321,500 shares $103,415.00 -49.7%0.9%0 $4.81
9/15/202342,700 shares $251,076.00 +26.3%1.9%0 $5.88
8/31/202333,800 shares $180,830.00 +15.4%1.6%0 $5.35
8/15/202329,300 shares $160,857.00 -47.0%1.4%0 $5.49
7/31/202355,300 shares $345,625.00 -87.4%3.3%0 $6.25
7/15/2023438,800 shares $3.50 million +949.8%27.6%0.4 $7.97
6/30/202341,800 shares $162,602.00 +7.2%2.6%0 $3.89
6/15/202339,000 shares $248,040.00 -42.8%2.5%0.1 $6.36
5/31/202368,200 shares $458,986.00 +121.4%4.3%0.1 $6.73
5/15/202330,800 shares $335,720.00 -42.4%1.9%0.1 $10.90
4/30/202353,500 shares $395,900.00 -74.1%3.7%0.2 $7.40
4/15/2023206,200 shares $1.60 million +320.8%14.1%0.9 $7.78
3/31/202349,000 shares $122,990.00 +260.3%3.4%0.2 $2.51
3/15/202313,600 shares $39,644.00 -40.9%0.9%0.1 $2.92
2/28/202323,000 shares $73,830.00 -3.0%1.6%0.2 $3.21
2/15/202323,700 shares $93,141.00 -30.3%1.6%0.2 $3.93
1/31/202334,000 shares $138,720.00 -18.5%2.5%0.3 $4.08
1/15/202341,700 shares $195,156.00 +152.7%3.1%0.4 $4.68
12/30/202216,500 shares $30,030.00 -16.2%0.9%0.2 $1.82
12/15/202219,700 shares $52,993.00 +97.0%1.1%1.7 $2.69
11/30/202210,000 shares $1,360.00 -97.8%0.8%1 $0.14
11/15/2022462,600 shares $63,048.68 +13.0%0.9%2.2 $0.14
10/31/2022409,300 shares $59,021.06 +7.2%0.8%2.1 $0.14
10/15/2022381,800 shares $61,088.00 +1.1%0.7%1.9 $0.16
9/30/2022377,800 shares $64,226.00 -11.9%0.7%1.9 $0.17
9/15/2022428,800 shares $96,179.84 +1.9%0.8%1.8 $0.22
8/31/2022420,900 shares $151,524.00 +0.8%0.8%2 $0.36
8/15/2022417,500 shares $146,125.00 -5.1%3.2%1.8 $0.35
7/31/2022440,000 shares $118,888.00 -3.5%3.4%1.8 $0.27
7/15/2022456,100 shares $136,830.00 -4.1%3.5%1.9 $0.30
6/30/2022475,500 shares $126,958.50 -2.4%3.6%1.9 $0.27
6/15/2022487,400 shares $124,335.74 -4.8%3.7%2.1 $0.26
5/31/2022511,800 shares $153,591.18 -15.2%1.0%2.3 $0.30
5/15/2022603,800 shares $185,608.12 -4.2%1.2%2.9 $0.31
4/30/2022630,400 shares $212,381.76 +1.2%1.2%3.3 $0.34
4/15/2022623,100 shares $281,890.44 -0.4%1.2%3.3 $0.45
3/31/2022625,400 shares $350,161.46 -1.9%N/A3.2 $0.56
3/15/2022637,600 shares $270,980.00 -4.5%1.2%2.3 $0.43
2/28/2022667,700 shares $295,457.25 -5.1%1.3%1.3 $0.44













ELOX Short Interest - Frequently Asked Questions

What is Eloxx Pharmaceuticals' current short interest?

Short interest is the volume of Eloxx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 35,700 shares of ELOX short. 1.49% of Eloxx Pharmaceuticals' shares are currently sold short. Learn More on Eloxx Pharmaceuticals' current short interest.

What is a good short interest ratio for Eloxx Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELOX shares currently have a short interest ratio of 1.0. Learn More on Eloxx Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Eloxx Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eloxx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Eloxx Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.49% of Eloxx Pharmaceuticals' floating shares are currently sold short.

Is Eloxx Pharmaceuticals' short interest increasing or decreasing?

Eloxx Pharmaceuticals saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 35,700 shares, an increase of 66.0% from the previous total of 21,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Eloxx Pharmaceuticals' float size?

Eloxx Pharmaceuticals currently has issued a total of 3,140,000 shares. Some of Eloxx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eloxx Pharmaceuticals currently has a public float of 2,400,000 shares.

How does Eloxx Pharmaceuticals' short interest compare to its competitors?

1.49% of Eloxx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Eloxx Pharmaceuticals: Windtree Therapeutics, Inc. (1.88%), Palisade Bio, Inc. (1.11%), Scinai Immunotherapeutics Ltd. (0.44%), Kiromic BioPharma, Inc. (4.01%), TC Biopharm (Holdings) Plc (30.51%), Avalon GloboCare Corp. (1.16%), Finch Therapeutics Group, Inc. (0.62%), NanoString Technologies, Inc. (12.55%), Fresh Tracks Therapeutics, Inc. (0.17%), TRACON Pharmaceuticals, Inc. (2.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

What does it mean to sell short Eloxx Pharmaceuticals stock?

Short selling ELOX is an investing strategy that aims to generate trading profit from Eloxx Pharmaceuticals as its price is falling. ELOX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eloxx Pharmaceuticals?

A short squeeze for Eloxx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELOX, which in turn drives the price of the stock up even further.

How often is Eloxx Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELOX, twice per month. The most recent reporting period available is October, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ELOX) was last updated on 2/29/2024 by MarketBeat.com Staff